Health Trials

Immunoproliferative Disorders

2

Review clinical trials related to Immunoproliferative Disorders. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

The goal of this clinical trial is to evaluate the safety, tolerability, and recommended Phase 2 Dose (RP2D) of KLN-1010 in patients with relapsed or refractory multiple myeloma.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Kelonia Therapeutics, Inc.Updated: Apr 24, 2026Locations: 7
Eligibility criteria

Participants must have relapsed and refractory multiple myeloma (RRMM) with meas... [+3]

Participants must not have known central nervous system (CNS) involvement with m... [+3]

Read more
Status: Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

The is a first clinical study for Oricell Therapeutics Inc. in the United States to evaluate the safety, PK, PD and preliminary efficacy of our anti-GPRC5D cell product (OriCAR-017) in subjects with relapsed/refractory multiple myeloma. RIGEL Study

Participants needed: 81
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: OriCell Therapeutics Co., Ltd.Updated: Aug 2, 2024Locations: 1
Eligibility criteria

Not listed

Read more